Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?
- PMID: 18172610
- DOI: 10.1007/s00210-007-0242-y
Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?
Abstract
This review discusses the available evidence concerning the use of anticholinergic drugs, alone or in combination with alpha-adrenoceptor antagonists, in men with lower urinary tract symptoms due to benign prostatic hyperplasia, benign prostatic enlargement, or benign prostatic obstruction and concomitant overactive bladder syndrome. We emphasize the safety and efficacy of anticholinergic agents in treating men with benign prostatic obstruction. Several recent studies of men with an overactive bladder suggest that combination therapy of anticholinergic and alpha-adrenoceptor antagonists improves the symptoms effectively without increasing the incidence of acute urinary retention.
Similar articles
-
Safety of anticholinergics in patients with benign prostatic hyperplasia.Expert Opin Drug Saf. 2008 Jul;7(4):473-9. doi: 10.1517/14740338.7.4.473. Expert Opin Drug Saf. 2008. PMID: 18613810 Review.
-
Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents?Curr Opin Urol. 2004 Jan;14(1):13-6. doi: 10.1097/00042307-200401000-00003. Curr Opin Urol. 2004. PMID: 15091043 Review.
-
Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.Pharmacotherapy. 2008 Mar;28(3):356-65. doi: 10.1592/phco.28.3.356. Pharmacotherapy. 2008. PMID: 18294115 Review.
-
Long-term efficacy of a combination therapy with an anticholinergic agent and an α1-blocker for patients with benign prostatic enlargement complaining both voiding and overactive bladder symptoms: A randomized, prospective, comparative trial using a urodynamic study.Neurourol Urodyn. 2017 Mar;36(3):748-754. doi: 10.1002/nau.23013. Epub 2016 Apr 6. Neurourol Urodyn. 2017. PMID: 27060991 Clinical Trial.
-
[Differential diagnosis and therapy examined under the microscope. LUTS (lower urinary tract symptoms) due to OAB (overactive bladder) - a frequent disease picture in the man].MMW Fortschr Med. 2011 Mar 31;153(13):44-5. MMW Fortschr Med. 2011. PMID: 21638816 German. No abstract available.
Cited by
-
The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum.World J Urol. 2011 Apr;29(2):149-55. doi: 10.1007/s00345-011-0655-6. Epub 2011 Feb 19. World J Urol. 2011. PMID: 21336600 Free PMC article.
-
Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.World J Urol. 2010 Feb;28(1):3-8. doi: 10.1007/s00345-009-0480-3. Epub 2009 Oct 9. World J Urol. 2010. PMID: 19816692 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical